Free Trial

Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Purchased by Gotham Asset Management LLC

Omega Healthcare Investors logo with Finance background

Gotham Asset Management LLC lifted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 17.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 421,883 shares of the real estate investment trust's stock after buying an additional 62,621 shares during the period. Gotham Asset Management LLC owned approximately 0.16% of Omega Healthcare Investors worth $15,968,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in OHI. Stonebridge Financial Group LLC purchased a new position in Omega Healthcare Investors in the fourth quarter valued at $26,000. Grove Bank & Trust acquired a new position in shares of Omega Healthcare Investors in the 4th quarter valued at $30,000. Kentucky Trust Co acquired a new stake in Omega Healthcare Investors during the 4th quarter worth $38,000. UMB Bank n.a. grew its holdings in shares of Omega Healthcare Investors by 68.6% during the fourth quarter. UMB Bank n.a. now owns 1,116 shares of the real estate investment trust's stock worth $42,000 after purchasing an additional 454 shares during the last quarter. Finally, V Square Quantitative Management LLC increased its position in shares of Omega Healthcare Investors by 44.5% during the fourth quarter. V Square Quantitative Management LLC now owns 1,410 shares of the real estate investment trust's stock worth $53,000 after purchasing an additional 434 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $35.86 on Friday. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. The stock has a market cap of $10.38 billion, a PE ratio of 23.14, a P/E/G ratio of 1.09 and a beta of 0.73. Omega Healthcare Investors, Inc. has a 1 year low of $30.48 and a 1 year high of $44.42. The stock has a fifty day moving average price of $37.50 and a 200 day moving average price of $38.16.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its earnings results on Thursday, May 1st. The real estate investment trust reported $0.75 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.75. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. The firm had revenue of $228.38 million for the quarter, compared to analyst estimates of $236.61 million. During the same quarter in the prior year, the company earned $0.68 EPS. Omega Healthcare Investors's revenue was up 13.8% on a year-over-year basis. Sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Monday, May 5th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Monday, May 5th. This represents a $2.68 annualized dividend and a yield of 7.47%. Omega Healthcare Investors's payout ratio is currently 166.46%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. JMP Securities reiterated a "market perform" rating on shares of Omega Healthcare Investors in a research note on Friday, February 7th. Wells Fargo & Company downgraded Omega Healthcare Investors from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $41.00 to $39.00 in a research note on Thursday, March 27th. Finally, Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $38.00 to $39.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $42.00.

Check Out Our Latest Research Report on Omega Healthcare Investors

About Omega Healthcare Investors

(Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Further Reading

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omega Healthcare Investors Right Now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines